Malaria Clinical Trial
Official title:
Reducing the Burden of Malaria by Targeting Hotspots of Transmission and Improving Malaria Control Measures in the Highlands of Western Kenya: Simultaneous Rollout of Four Malaria Control Interventions and Evaluation by Cross-sectional Surveys
In this study, the investigators propose to determine the value of rolling out four targeted
malaria control efforts in reducing overall malaria transmission. These targeted control
efforts include local upscaling of IRS and ITNs in hotspots of malaria transmission. In
addition, larviciding will be employed to target malaria vectors, also those that are less
susceptible to IRS and ITNs as a consequence of outdoor feeding and resting. Lastly, the
human infectious reservoir will be reduced in hotspots of malaria transmission by treating
parasite carriers and their household members with the current first-line antimalarial drug.
The impact of these targeted interventions on overall transmission intensity will be
assessed in the context of currently ongoing malaria control activities in a plausibility
study. Hotspots of malaria transmission are defined in an area of 100km2 and randomized to
receive hotspot targeted interventions and compared with their baseline and with control
clusters where the routine (untargeted) malaria control activities continue. The
interventions will be evaluated based on changes in parasite prevalence measured in
community surveys inside and outside hotspots of malaria transmission. Parasite prevalence
will be compared before and after the intervention in intervention clusters and between
intervention and control clusters.
In addition to malaria surveys in the human population, an entomological evaluation will
take place where the densities of mosquito larvae and adult mosquitoes are monitored
longitudinally.
DEFINITIONS This study uses a plausibility design to determine the plausible impact of
hotspot-targeted interventions on overall malaria transmission. Hotspots will be detected in
the 100km2 study area. Hotspots are defined as areas with a level of transmission intensity
that exceeds that in the surrounding area; indicated by a higher sero-conversion rate and/or
age-adjusted density of malaria-specific antibodies.
Clusters for the intervention are defined as a hotspot and the area surrounding this hotspot
in each direction up to 500 meters.
INTERVENTION Half of the clusters will be randomized to hotspot-targeted interventions,
while the other half will serve as control. The plausible impact of hotspot targeted
interventions will be evaluated by comparing malaria indices in intervention clusters with
their baseline and with control clusters.
In each phase four hotspot-targeted interventions will be superimposed on ongoing control
measures: hotspots will be targeted with a combination IRS, long-lasting insecticide treated
nets (LLINs), larviciding and a focal screening and treatment (FSAT).
EVALUATION The primary outcome will be parasite prevalence in evaluation zones (i.e. the
area surrounding malaria hotspots) of targeted and untargeted clusters. In addition,
parasite prevalence will be determined inside hotspots of malaria transmission and in
evaluation zones in relation to distance to the hotspot boundary. For this, community
surveys are planned prior to the intervention and at two time-points after the intervention.
An entomological evaluation will take place concurrently in which mosquito breeding sites
are monitored for productivity and mosquitoes will be sampled indoors and outdoors.
Malaria morbidity is assessed by passive case detection.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
| Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
| Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
| Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
| Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
| Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
| Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
| Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
| Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
| Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
| Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
| Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
| Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
| Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
| Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
| Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
| Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
| Completed |
NCT02315690 -
Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland
|
Phase 3 |